Things
The HEAL ITALIA program promotes a scheme based on cascade funding to support Proof-of-Concept (Po C) projects with industrial research and experimental development processes involving companies, specialized clinical centres, IRCCS, healthcare companies, Research organisations, foundations, consortium companies, SMEs, start-ups, spin-offs and other entities interested in the creation/implementation of valorisation and acceleration programs activated by the spokes and managed in collaboration with the HUB. The objective is to increase the levels of technological maturity (TRL - Technology Readiness Levels) envisaged by the HEAL ITALIA Programme, through the involvement of subjects external to the Extended Partnership, strongly interested in introducing/implementing significant innovations that act as a trailblazer and/or as tool for accelerating and specializing the activities carried out by the Spokes for the search for technologically advanced solutions, in relation to products, processes and services transferable to the areas of intervention of Precision Medicine. This Notice supports proposals relating to activities that envisage reaching a level of technological maturity TRL > 3. Support therefore from the early research phases, mainly referring to the development/implementation of technologies with extremely advanced content, including conceptual verification and prototypes for the validation of the technology, demonstration activities for pilot projects and feasibility studies also in order to evaluate high potential activities and support the creation of spin-offs and start-ups. Applications may be submitted whose project proposals fall within the scope of application of Precision Medicine as defined in the "Guidelines for system initiatives of Mission 4: Education and Research - Component 2: From Research to Enterprise" of the Ministry of University and Research (DM MUR n.1141 of 07-10-2021), are consistent with the objectives of Spoke 2 and provide for a measurable impact also on the areas of specialization of the HEAL ITALIA Programme.
Who is it aimed at?
Who it is aimed at: The following can apply (provided they are external to the HEAL ITALIA partnership): – Micro, Small and Medium-sized enterprises; – Innovative startups established no more than 24 months ago; – Large companies; – Foreign companies with an operational headquarters on Italian territory (i.e. which undertake to activate an office in Italy by the date of signature of the provision granting the relief). Only for topics 2 and 3: – Universities and bodies supervised by the MUR; – Research organizations registered in the National Research Registry; – Consortium companies and consortia of international importance, provided that at least one partner has an operational unit in Italy.
What does it predict
Profile sought: Interventions in the form of industrial research and/or experimental development projects can be financed individually or in collaboration. Collaborative projects can involve a maximum of 4 entities with homogeneous operational locations in terms of financial resources (Regions of Northern/Central Italy or Regions of Southern Italy). The projects must be consistent with the planned themes.
